It has been revealed that the Veteran Actor, Dr Jerry Mofekeng from Scandal is going under a treatment.Apparently the actor playing the role Neo Mokhethi on Scandal undergoes prostate cancer treatment.The etv soapie has took the matter to social media platform to inform about Dr Jerry Mofokeng's cancer journey.
Scandal also revealed that they will also navigate Dr Jerry Mofokeng on their storyline as exploring his real-life story to let people know about the "prostate cancer".
The Veteran Actor was diagnosed back in 2019 and immediately started his treatment.Now Scandal want to share the real-life story of Dr Jerry Mofokeng as a way of educating South Africans about prostate cancer.Apparently this comes after they realized that South African men do not really talk about the cancer and people tend to lose their lives.
South Africans only need to pray for Dr Jerry Mofokeng to get better and beat the cancer.
Source: Updates With LolaM
Content created and supplied by: Pforsimple (via Opera News )
Opera News is a free to use platform and the views and opinions expressed herein are solely those of the author and do not represent, reflect or express the views of Opera News. Any/all written content and images displayed are provided by the blogger/author, appear herein as submitted by the blogger/author and are unedited by Opera News. Opera News does not consent to nor does it condone the posting of any content that violates the rights (including the copyrights) of any third party, nor content that may malign, inter alia, any religion, ethnic group, organization, gender, company, or individual. Opera News furthermore does not condone the use of our platform for the purposes encouraging/endorsing hate speech, violation of human rights and/or utterances of a defamatory nature. If the content contained herein violates any of your rights, including those of copyright, and/or violates any the above mentioned factors, you are requested to immediately notify us using via the following email address operanews-external(at)opera.com and/or report the article using the available reporting functionality built into our Platform See More